25
Participants
Start Date
June 30, 2011
Primary Completion Date
December 31, 2011
Study Completion Date
December 31, 2012
ONO-5334
150 mg for 5 days administered in the morning or in the evening
ONO-5334
150 mg QD for one day. Administered either in the fasted state or after the standard meal or high fat meal.
Guildford Clinical Site, Guildford
London Clinical Site, London
Lead Sponsor
Ono Pharmaceutical Co. Ltd
INDUSTRY